# Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia

> **NCT02420015** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 35 (actual)

## Conditions studied

- Schizophrenia
- Cigarette Smoking

## Interventions

- **DRUG:** Nicotine replacement therapy
- **DRUG:** Bupropion
- **BEHAVIORAL:** cognitive-behavioral smoking cessation counseling
- **BEHAVIORAL:** Mobile Contingency Management
- **BEHAVIORAL:** Stay Quit Coach
- **BEHAVIORAL:** SMS text messaging

## Key facts

- **NCT ID:** NCT02420015
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-01-24
- **Final completion:** 2019-01-24
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02420015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02420015, "Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02420015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*